underperforming research initiatives

See the following -

Stanford’s John Ioannidis On “Underperforming Big Ideas”

Press Release | Stanford Medicine | July 28, 2016

In a thought-provoking JAMA commentary out today, Stanford’s John Ioannidis, MD, DSc, and two colleagues call for biomedical researchers — and funding institutions — to “sunset underperforming initiatives.” Nothing controversial there, until you go on to read that some of those initiatives are in the popular fields of gene therapy, stem cell therapy or precision medicine. And, they write, perhaps some less-successful projects have been pursued simply because they fall within a top research field.

Read More »